Home | MyCME | All CME | Blog | Psychlopedia

Overview

Faculty

Activities in This Series

The Impact of Oral Medications on the Treatment of Multiple Sclerosis

Supported by an educational grant from Genzyme, a Sanofi Company, and Novartis Pharmaceuticals Corporation.

Neurology Reports
Potential Barriers to Oral MS Medications

Potential Barriers to Oral MS Medications

CME Expired 05/31/2017

The Impact of Oral Medications on the Treatment of Multiple Sclerosis

Supported by an educational grant from Genzyme, a Sanofi Company, and Novartis Pharmaceuticals Corporation.

Neurology Reports
Current Standards of Treatment in MS and the Role of Oral Agents

Current Standards of Treatment in MS and the Role of Oral Agents

CME Expired 05/31/2017

The Impact of Oral Medications on the Treatment of Multiple Sclerosis

Supported by an educational grant from Genzyme, a Sanofi Company, and Novartis Pharmaceuticals Corporation.

Neurology Reports
Switching Therapies in MS

Switching Therapies in MS

CME Expired 12/31/2017

The Impact of Oral Medications on the Treatment of Multiple Sclerosis

Supported by an educational grant from Genzyme, a Sanofi Company, and Novartis Pharmaceuticals Corporation.

Neurology Reports
Addressing Unmet Therapeutic Needs in MS

Addressing Unmet Therapeutic Needs in MS

CME Expired 12/31/2017